Lifestyle
- Regular exercise
- Stress management
- Adequate sleep
Immunoglobulin G · IgG
IgG measures the concentration of immunoglobulin G antibodies in the blood, reflecting immune system activity.
Reference ranges can vary slightly based on laboratory and population. Age and sex-specific differences may apply.
Immunoglobulin G (IgG) is a type of antibody that plays a crucial role in the body's immune response by identifying and neutralizing foreign objects like bacteria and viruses. It is the most abundant type of antibody found in blood circulation. Researchers have observed that IgG is involved in various immune processes, including the activation of other immune cells and the facilitation of phagocytosis. Clinically, IgG levels are significant as they can reflect the state of an individual's immune system. Elevated IgG levels may indicate chronic infections, autoimmune diseases, or chronic inflammation, while low levels can suggest immunodeficiency or acute infection. In the context of athletic performance and biohacking, IgG is relevant as it can indicate the body's ability to respond to infections and recover from physical stress. For longevity, maintaining balanced IgG levels is associated with healthy aging, as researchers have found that changes in IgG glycosylation patterns are linked to inflammaging. Caveats in measuring IgG include potential confounders such as recent infections or vaccinations, which can temporarily alter IgG levels. Additionally, IgG levels can vary with age and sex, and certain medications may interfere with accurate measurement.
Klinische Bedeutung
Elevated IgG levels may indicate chronic infections, autoimmune diseases, or chronic inflammation. Reduced IgG levels can suggest immunodeficiency or acute infection.
Progressively rising IgG levels may suggest chronic infection or autoimmune activity. Retesting is recommended in 4-6 weeks if levels are outside the normal range.
Falling IgG levels could indicate resolving infection or immunosuppression.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before making significant changes to diet or lifestyle, especially if underlying health conditions exist.
Testing Frequency
Annually for healthy adults or as advised by a healthcare provider.
Current research suggests that reference ranges for immunoglobulin G (IgG) glycosylation patterns in aging and their implications for inflammation modulation remain understudied. Researchers have not yet established optimal targets for IgG avidity assays in distinguishing recent from distant infections, particularly in diverse populations. Additionally, clinical questions regarding the long-term implications of NMO-IgG seropositivity on treatment outcomes in neuromyelitis optica remain unanswered.
1,252
Total Citations
14
Human/RCT
10.3
Avg. Influence
2025
Latest
Researchers found that glial fibrillary acidic protein (GFAP)-IgG is a specific biomarker for a novel autoimmune central nervous system disorder. The study analyzed 102 patients and reported high specificity and sensitivity for GFAP-IgG in cerebrospinal fluid testing. The findings suggest that GFAP-IgG detection can indicate an immunotherapy-responsive condition.
Researchers found that the glycosylation patterns of Immunoglobulin G (IgG) vary significantly with age and disease states, making it a potential biomarker for general health. They noted that changes in IgG glycosylation can influence immune function and may play a role in disease progression, suggesting its analysis could enhance existing disease biomarkers.
This study described familial neuromyelitis optica (NMO) and its association with aquaporin-4-specific IgG. Researchers found that a significant proportion of affected individuals were NMO-IgG positive, indicating a genetic component to the disease. The findings suggest that familial occurrence of NMO may be more common than previously thought.
This study focused on cerebrospinal fluid (CSF) analysis for diagnosing multiple sclerosis (MS). Researchers found that intrathecal immunoglobulin G (IgG) synthesis is crucial for confirming MS and that kappa free light chains (κ-FLCs) could serve as a new biomarker with high diagnostic accuracy. The study recommends including κ-FLC synthesis in future MS diagnostic criteria.
This study reported on autoimmune cerebellar ataxia associated with antibodies targeting septin-5. Researchers observed that IgG from affected patients showed specific staining patterns in brain tissues. The findings suggest that septin-5 IgG could serve as a biomarker for this potentially treatable condition.
Researchers reviewed high-throughput methods for analyzing Immunoglobulin G (IgG) glycosylation, which is important for understanding its functional relevance in health and disease. They emphasized the need for robust and affordable methodologies to facilitate the discovery of glycan biomarkers in clinical settings.
Researchers reviewed the role of Immunoglobulin G (IgG) glycans in aging, highlighting their potential as biomarkers and molecular effectors. They summarized studies on how IgG glycosylation patterns change with age and discussed the implications of these changes for understanding the aging process and age-related diseases.
This study investigated the relationship between glycosylation and aging, particularly the N-glycome of immunoglobulin G (IgG). Researchers found that changes in IgG glycosylation patterns may modulate inflammation levels and could serve as a biomarker for healthy aging. The study discusses potential interventions that could influence IgG glycopatterns.
This study reviewed biochemical biomarkers for diagnosing multiple sclerosis (MS). Researchers found that the presence of immunoglobulin G oligoclonal bands (OCB) in cerebrospinal fluid is a key diagnostic marker. The study also discusses the potential of kappa free light chains (κ-FLCs) as a more sensitive biomarker for MS.
Researchers summarized the impact of Immunoglobulin G (IgG) glycosylation on tumor immunity and progression. They noted that specific glycosylation modifications correlate with tumor characteristics, suggesting that IgG glycosylation could be a target for improving tumor diagnosis and treatment strategies.
Research publications about Immunglobulin G over time
9totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer